$Inogen (INGN.US)$ Inogen Expands Product Portfolio, Global Reach and Innovation Pipeline Through Strategic Collaboration With Yuwell Sunday, 26th January at 12:00 pm Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced it has entered into a strategic collaboration with Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (002223.SZ, "Yuwell"), a global home healthcare medical device manufacturer...
$Inogen (INGN.US)$ Inogen Receives FDA 510(k) Clearance for SIMEOX 200 Airway Clearance Device Monday, 30th December at 8:30 am Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the SIMEOX 200 Airway Clearance Device, expanding the company's ability to market and meet the various needs of patients with chronic...
$Inogen (INGN.US)$ Second Quarter 2024 Financial Results Second quarter total revenue increased 6.1% to $88.8 million from $83.6 million in the second quarter of 2023, primarily driven by higher demand and new customers in international and domestic business-to business sales, partially offset by lower direct-to-consumer sales and rental revenue. Total gross margin was 48.1% in the second quarter of 2024 versus 40.7% in the comparative period in 2023. The increase was driven primarily by low...
Investors' belief that strong revenue growth is not on the horizon for Inogen contributes to its low P/S ratio. The company's underwhelming revenue outlook is a major factor. A change of fortune is needed to justify a higher P/S in the future.
$Inogen (INGN.US)$ An authorized Inogen dealer I work with said that Inogen G4s and G5s are failing more than half of the time forcing them to return them to Inogen. Inogen sells these devices directly to the public and I have to assume Innogen is not performing the additional testing that the dealer is doing or they would be finding the defective POCs before shipping. The specific defect mentioned is the device not recognizing the battery when AC power is disconnected. I would imagine that if the dealer is telling the truth (I have it in writing) there will be a recall on Inogen devices.
1
1
Report
easygoing Lyon
:
my Mother in law has COPD her Inogens all work great!
$Inogen (INGN.US)$ER 24th ,WATCH DD.This is the Imogen 1 Portable Oxygen You're Seeing On TV Every Couple Hours On TV Every Day 😉 Think About The Money That's Being Made-Real Bucks minus Commercials 🤑
Report
No comment yet
- No more -
Sign in to post a comment
Trending Stocks
Top Gaining Chinese Stocks Top Gaining Chinese Stocks
Inogen Stock Forum
Inogen Expands Product Portfolio, Global Reach and Innovation Pipeline Through Strategic Collaboration With Yuwell
Sunday, 26th January at 12:00 pm
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced it has entered into a strategic collaboration with Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (002223.SZ, "Yuwell"), a global home healthcare medical device manufacturer...
Inogen Receives FDA 510(k) Clearance for SIMEOX 200 Airway Clearance Device
Monday, 30th December at 8:30 am
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the SIMEOX 200 Airway Clearance Device, expanding the company's ability to market and meet the various needs of patients with chronic...
Second Quarter 2024 Financial Results
Second quarter total revenue increased 6.1% to $88.8 million from $83.6 million in the second quarter of 2023, primarily driven by higher demand and new customers in international and domestic business-to business sales, partially offset by lower direct-to-consumer sales and rental revenue.
Total gross margin was 48.1% in the second quarter of 2024 versus 40.7% in the comparative period in 2023. The increase was driven primarily by low...
An authorized Inogen dealer I work with said that Inogen G4s and G5s are failing more than half of the time forcing them to return them to Inogen. Inogen sells these devices directly to the public and I have to assume Innogen is not performing the additional testing that the dealer is doing or they would be finding the defective POCs before shipping. The specific defect mentioned is the device not recognizing the battery when AC power is disconnected. I would imagine that if the dealer is telling the truth (I have it in writing) there will be a recall on Inogen devices.
No comment yet